The landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Has a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Sun Pharma is expected to post double-digit revenue growth in Q4FY26, driven by strong performance across speciality drugs, domestic formul...

Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...

President Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

Eli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...

Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

The Indian government's mandate for physicians to prescribe only generic drug names is facing challenges in execution, according to Fitch R...

All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for...

Generic drugs sold under a brand name given by the manufacturer are called branded generics. In India, 90% of the pharma market is made up ...

The issue of generic drug prescription returned to the spotlight after PM Modi said that the govt would bring in a law to force doctors to ...

The MCI has also asked the medical practitioners to ensure that there is rational prescription and use of drugs, failing which action will ...

Fear of misinterpretation due to doctor's illegible handwriting may soon be a thing of the past as government is set to make it a norm for ...